Patients
The humans the algorithms can't reach
Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.
R&D
On genomics, NGS, and doing much more good than bad, with Ma...
Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Sales & Marketing
Breaking tradition to reimagine medical affairs workflows fo...
To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.
Market Access
Women's health: Predictions for 2026
A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.
R&D
Beyond good intentions: How life sciences can prove its read...
While support for reducing animal use has never been stronger, the path to broad adoption is steep and complex.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
